24
Participants
Start Date
May 31, 2014
Primary Completion Date
August 2, 2019
Study Completion Date
August 2, 2019
AZD8931
160 mg AZD8931 tablets, twice daily on days 1 - 4 of each 2-weekly cycle
Irinotecan
180 mg/m2 (IV infusion) of Irinotecan on day 1 of each 2-weekly cycle - can be given simultaneously with Folinic acid.
Folinic Acid
350 mg (IV infusion) of Folinic acid on day 1 of each 2-weekly cycle - can be given simultaneously with Irinotecan.
Fluorouracil
400 mg/m2 (IV bolus) of Fluorouracil on day 1 of each 2-weekly cycle, to be given after completion of Irinotecan and Folinic acid.
Fluorouracil
2400 mg/m2 (IV) continuous infusion of Fluorouracil given over 46 hours - infusion to start after 5FU bolus.
Barts Health NHS Trust, London
Guy's and St Thomas' NHS Foundation Trust, London
University College London Hospital NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Collaborators (2)
Cancer Research UK
OTHER
AstraZeneca
INDUSTRY
National Institute for Health Research, United Kingdom
OTHER_GOV
University College, London
OTHER